Item 8.01. Other Information.

On January 7, 2021, Oragenics, Inc. ("Oragenics" or the "Company") issued a press release announcing the Company entered into a material transfer agreement with Adjuvance Technologies Inc. for a COVID-19 vaccine adjuvant.

A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.   Description

   99.1         Press Release dated January 7, 2021.

© Edgar Online, source Glimpses